Oral Colchicine in Argentina to Prevent Restenosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 410 participants.
Also called NCT04382443
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 410 participants
- Sponsor
- Centro de estudios en Cardiologia Intervencionista
- Registry
-
NCT04382443
-
- Main results
- Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary intervention
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Argentina
- Registry status
- Completed
Technical summary
Registry record NCT04382443. Randomized; no masking; primary purpose treatment. Start 2020-03-12 (actual); primary completion 2022-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Oral Colchicine in Argentina to Prevent Restenosis
- Acronym
- ORCA
- Condition
- Coronary Artery Disease
- Condition
- Restenosis of Coronary Artery Stent
- Condition
- Atherosclerosis
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Colchicine
- Lead sponsor
- Centro de estudios en Cardiologia Intervencionista
Record details
- Record id
cardio:ct-nct04382443- Content hash
0009c918d21c8a42f87b6a4405f59fbf3b4d6a6cba715e0354b771e3d60f6112